02831nam 2200577 450 991078759280332120230803030544.01-78084-174-4(CKB)2670000000391302(EBL)1179667(OCoLC)851970672(SSID)ssj0001599988(PQKBManifestationID)16306413(PQKBTitleCode)TC0001599988(PQKBWorkID)14892859(PQKB)11460261(MiAaPQ)EBC1179667(Au-PeEL)EBL1179667(EXLCZ)99267000000039130220220517d2013 uy 0engur|n|---|||||txtccrPolycystic kidney disease from bench to bedside /editors, Vincent H. Gattone, Robert L. Bacall1st ed.London, England :Future Medicine Ltd.,[2013]©20131 online resource (195 p.)Description based upon print version of record.1-78084-176-0 Title page; Copyright page; Contents; Foreword. Polycystic kidney disease: from bench to bedside; 1. Polycystic kidney disease: genes, prevalence and diagnosis; 2. Polycystins and the pathophysiology of autosomal dominant polycystic kidney disease; 3. Fibrocystin/polyductin and pathophysiology of autosomal recessive polycystic kidney disease; 4. Nephronophthisis; 5. Meckel syndrome; 6. The Bardet-Biedl and orofacial digital type I ciliopathies; 7. Pain and pain management in polycystic kidney disease; 8. Hypertension in autosomal dominant polycystic kidney disease9. Complications of polycystic kidney disease10. End-stage renal disease in polycystic kidney disease; 11. Preclinical and clinical trials for identifying treatments for polycystic kidney disease; IndexRecent years have seen advances in our understanding the molecular cell biology, signaling and pathogenesis of one of the most common life-threatening genetic diseases - polycystic kidney disease (PKD). This multichapter work from international experts opens with chapters exploring the pathogenesis and pathophysiology of autosomal dominant and autosomal recessive PKD.Polycystic kidney diseasePolycystic kidney diseaseDiagnosisPolycystic kidney diseaseTreatmentPolycystic kidney disease.Polycystic kidney diseaseDiagnosis.Polycystic kidney diseaseTreatment.616.61042Gattone Vincent H.Bacall Robert L.MiAaPQMiAaPQMiAaPQBOOK9910787592803321Polycystic kidney disease2859144UNINA